Autopsy report · NCT03410628

Non-invasive Neurostimulation for the Relief of Migraine

“Company decision”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 8 months after it had already started.
• Ran for about 5 months before it stopped.
• 21 participants enrolled.
• Results were posted on the registry 6 years 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

ElectroCore INC

Sponsor type

Industry

Conditions

Migraine

Interventions

gammaCore

Participants

21

Trials that died the same way

• 3D011-08 Monotherapy in Subjects With Advanced Solid Tumors
  “Company's decision” (97% match in meaning)
• V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficiency Due to Leaflet Prolapse
  “Company business decision” (92% match in meaning)
• A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors
  “Corporate decision” (90% match in meaning)
• Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B
  “Business decision” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.